Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: Results of the GRAALL AFR09 study

Leukemia

Volumn 20, Issue 9, 2006, Pages 1526-1532

  Delannoy, A ^a   Delabesse, E ^b   Lheritier V ^c   Castaigne, S ^d   Rigal Huguet, F ^e   Raffoux, E ^f   Garban, F ^g   Legrand, O ^h   Bologna, S ⁱ   Dubruille, V ^j   Turlure, P ^k   Reman, O ^l   Delain, M ^m   Isnard, F ⁿ   Coso, D ^o   Raby, P ^p   Buzyn, A ^b   Cailleres S ^q   Darre, S ^r   Fohrer, C ^s   Sonet, A ^t   Bilhou Nabera, C ^u   Bene M C ⁱ   Dombret, H ^f   Berthaud, P ^v   Thomas, X ^c   more..

^a Hospital de Jolimont   (Belgium)

^b Section of Radiology   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d CENTRE HOSPITALIER DE VERSAILLES   (France)

^e CHU PURPAN   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g HÔPITAL MICHALLON   (France)

^h HÔTEL DIEU   (France)

ⁱ CHU NANCY BRABOIS   (France)

^j HÔTEL DIEU   (France)

^k DUPUYTREN UNIVERSITY HOSPITAL   (France)

^l CAEN UNIVERSITY HOSPITAL   (France)

^m CHU BRETONNEAU   (France)

ⁿ HÔPITAL SAINT ANTOINE   (France)

^o INSTITUT PAOLI CALMETTES   (France)

^p Pasteur Hospital   (France)

^q Hôpital C Huriez ^*  (France)

^r LILLE UNIVERSITY HOSPITAL   (France)

^s HÔPITAL DE HAUTEPIERRE   (France)

^t UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^u HAUT LÉVÊQUE HOSPITAL   (France)

^v NOVARTIS PHARMA K K   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; IMATINIB; INTERFERON; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; TIOGUANINE; VINCRISTINE; VINDESINE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLEEDING; BRAIN ISCHEMIA; BRAIN RADIATION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG RESPONSE; ELDERLY CARE; FEMALE; HUMAN; HYPOFIBRINOGENEMIA; INFECTION; LEUKEMIA RELAPSE; LUNG ASPERGILLOSIS; LUNG EMBOLISM; MAINTENANCE THERAPY; MALE; MOOD DISORDER; MUSCLE ATROPHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHILADELPHIA CHROMOSOME POSITIVE CELL; POLYNEUROPATHY; PRIORITY JOURNAL; SALVAGE THERAPY; SEPTICEMIA; SKIN CANCER; STATISTICAL SIGNIFICANCE; STOMACH HEMORRHAGE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNILATERAL BLINDNESS; VEIN THROMBOSIS; VIRUS PNEUMONIA;

EID: 33747598699     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404320     Document Type: Article

References (14)

1. Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: Results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2357-2366.
2. Groupe Français de Cytogénétique Hématologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogenetique Hematologique. Blood 1996; 87: 3135-3142.
3. Houot R, Tavernier E, Le QH, Lheritier V, Thiebaut A, Thomas X. Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: Prognostic factors and treatment outcome. Hematology 2004; 9: 369-976.
4. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139-145.
5. Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965-1971.
6. Towatari M, Yanada M, Usui N, Takeuchi J, Sugiura I, Takeuchi M et al. Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Blood 2004; 104: 3507-3512.
7. Thomas DA, Faderl S, Cortes J, O'Brien S, Giles FJ, Komblau SM et al. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 2004; 103: 4396-4407.
8. Delannoy A, Cazin B, Thomas X, Bouabdallah R, Boiron JM, Huguet F et al. Treatment of acute lymphoblastic leukemia in the elderly: An evaluation of interferon alpha given as a single agent after complete remission. Leuk Lymphoma 2002; 43: 75-81.
9. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1965; 53: 457-481.
10. Vignetti M, Fazi P, Meloni G, Chiarenza A, Malagola A, Fabbiano F et al. Dramatic improvement in CR rate and CR duration with imatinib in adult and elderly Ph+ ALL patients: Results of the GIMEMA prospective study LAL0201. Blood 2004; 104: 749a (abstract).
11. Pfeifer H, Ottmann OG, Goekbuget N, Wunderle L, Brueck P, Giagounidis A et al. A randomized phase II study of single-agent imatinib versus chemotherapy therapy in elderly patients with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) including analysis of resistance patterns. Blood 2005; 106: 519a (abstract).
12. Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G et al. Treatment of adult acute lymphoblastic leukemia (ALL): Longterm follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-871.
13. Scheuring UJ, Pfeifer H, Wassmann B, Bruck P, Gehrke B, Petershofen EK et al. Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571). Blood 2003; 101: 85-90.
14. Pane F, Cimino G, Izzo B, Camera A, Vitale A, Quintarelli C et al. Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. Leukemia 2005; 19: 628-635.